tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
IO Biotech downgraded to Hold from Buy at TD Cowen
PremiumThe FlyIO Biotech downgraded to Hold from Buy at TD Cowen
1M ago
IO Biotech downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
IO Biotech downgraded to Neutral from Buy at H.C. Wainwright
1M ago
H.C. Wainwright downgrades IO Biotech after FDA recommends another Phase 3 trial
Premium
The Fly
H.C. Wainwright downgrades IO Biotech after FDA recommends another Phase 3 trial
1M ago
IO Biotech’s Cylembio Shows Promise Despite Missed Endpoint, Buy Rating Affirmed
PremiumRatingsIO Biotech’s Cylembio Shows Promise Despite Missed Endpoint, Buy Rating Affirmed
3M ago
Promising Phase 3 Results and Strategic FDA Engagement Bolster Buy Rating for IO Biotech
Premium
Ratings
Promising Phase 3 Results and Strategic FDA Engagement Bolster Buy Rating for IO Biotech
3M ago
IO Biotech Reveals Phase 3 Trial Results for Cylembio
Premium
Company Announcements
IO Biotech Reveals Phase 3 Trial Results for Cylembio
3M ago
IO Biotech Elects New Director at Annual Meeting
PremiumCompany AnnouncementsIO Biotech Elects New Director at Annual Meeting
5M ago
IO Biotech Regains Nasdaq Compliance with Stock Price
Premium
Company Announcements
IO Biotech Regains Nasdaq Compliance with Stock Price
5M ago
IO Biotech files to sell 5.62M shares of common stock for holders
Premium
The Fly
IO Biotech files to sell 5.62M shares of common stock for holders
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100